Novel Biologic for Sjogren's Clears Penultimate Hurdle

(MedPage Today) — CHICAGO — An investigational biologic against B-cell activating factor (BAFF) appeared effective in treating Sjögren’s disease in twin phase III trials, a researcher reported here, although salivation wasn’t enhanced…

Source link : https://www.medpagetoday.com/meetingcoverage/acr/118237

Author :

Publish date : 2025-10-30 18:36:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Novel Biologic for Sjogren’s Clears Penultimate Hurdle

Trump’s Surgeon General Pick Goes Into Labor, Senate Hearing Postponed

Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens

Related Posts

‘A Fiasco’; Diabetes Drugs and GI Cancer Risk; New Guidelines on Liver Transplants

HHS Moves to Halt Gender-Affirming Care for Youth

Establishing Connection and Trust With Breast Cancer Patients

How Often Does Dry Needling Lead to a Collapsed Lung?

Adult Congenital Heart Docs Should Be More Involved, Says New Guideline

Two asteroids crashed around a nearby star, solving a cosmic mystery

‘A Fiasco’; Diabetes Drugs and GI Cancer Risk; New Guidelines on Liver Transplants

HHS Moves to Halt Gender-Affirming Care for Youth

Establishing Connection and Trust With Breast Cancer Patients

How Often Does Dry Needling Lead to a Collapsed Lung?

Adult Congenital Heart Docs Should Be More Involved, Says New Guideline

Two asteroids crashed around a nearby star, solving a cosmic mystery

Precision Medicine in Sjogren’s Disease

Orforglipron Helps Maintain Weight Loss After Injectables

Categories

Archives